Literature DB >> 20668055

Interaction between sensory C-fibers and cardiac mast cells in ischemia/reperfusion: activation of a local renin-angiotensin system culminating in severe arrhythmic dysfunction.

Christopher Morrey1, Jacqueline Brazin, Nahid Seyedi, Federico Corti, Randi B Silver, Roberto Levi.   

Abstract

Renin, the rate-limiting enzyme in the activation of the renin-angiotensin system (RAS), is synthesized and stored in cardiac mast cells. In ischemia/reperfusion, cardiac sensory nerves release neuropeptides such as substance P that, by degranulating mast cells, might promote renin release, thus activating a local RAS and ultimately inducing cardiac dysfunction. We tested this hypothesis in whole hearts ex vivo, in cardiac nerve terminals in vitro, and in cultured mast cells. We found that substance P-containing nerves are juxtaposed to renin-containing cardiac mast cells. Chemical stimulation of these nerves elicited substance P release that was accompanied by renin release, with the latter being preventable by mast cell stabilization or blockade of substance P receptors. Substance P caused degranulation of mast cells in culture and elicited renin release, and both of these were prevented by substance P receptor blockade. Ischemia/reperfusion in ex vivo hearts caused the release of substance P, which was associated with an increase in renin and norepinephrine overflow and with sustained reperfusion arrhythmias; substance P receptor blockade prevented these changes. Substance P, norepinephrine, and renin were also released by acetaldehyde, a known product of ischemia/reperfusion, from cardiac synaptosomes and cultured mast cells, respectively. Collectively, our findings indicate that an important link exists in the heart between sensory nerves and renin-containing mast cells; substance P released from sensory nerves plays a significant role in the release of mast cell renin in ischemia/reperfusion and in the activation of a local cardiac RAS. This culminates in angiotensin production, norepinephrine release, and arrhythmic cardiac dysfunction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668055      PMCID: PMC2957783          DOI: 10.1124/jpet.110.172262

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  47 in total

Review 1.  Renin-angiotensin system: biochemistry and mechanisms of action.

Authors:  M J Peach
Journal:  Physiol Rev       Date:  1977-04       Impact factor: 37.312

Review 2.  Free radicals as endogenous histamine releasers.

Authors:  P F Mannaioni; E Giannella; B Palmerani; A Pistelli; F Gambassi; T Bani-Sacchi; S Bianchi; E Masini
Journal:  Agents Actions       Date:  1988-04

3.  Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog.

Authors:  James A Stewart; Chih Chang Wei; Gregory L Brower; Patricia E Rynders; Gerald H Hankes; A Ray Dillon; Pamela A Lucchesi; Joseph S Janicki; Louis J Dell'Italia
Journal:  J Mol Cell Cardiol       Date:  2003-03       Impact factor: 5.000

Review 4.  The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?

Authors:  D E Dostal; K M Baker
Journal:  Circ Res       Date:  1999-10-01       Impact factor: 17.367

5.  Reperfusion injury on cardiac myocytes after simulated ischemia.

Authors:  T L Vanden Hoek; Z Shao; C Li; R Zak; P T Schumacker; L B Becker
Journal:  Am J Physiol       Date:  1996-04

6.  Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart.

Authors:  P Eaton; J M Li; D J Hearse; M J Shattock
Journal:  Am J Physiol       Date:  1999-03

7.  Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion.

Authors:  Christina J Mackins; Seiichiro Kano; Nahid Seyedi; Ulrich Schäfer; Alicia C Reid; Takuji Machida; Randi B Silver; Roberto Levi
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

8.  Cardiac innervation and sudden cardiac death.

Authors:  Masaki Ieda; Keiichi Fukuda
Journal:  Curr Cardiol Rev       Date:  2009-11

Review 9.  Regulation of cardiac afferent excitability in ischemia.

Authors:  Liang-Wu Fu; John C Longhurst
Journal:  Handb Exp Pharmacol       Date:  2009

10.  Myocardial dysfunction and norepinephrine release in the isolated rat heart injured by electrolysis-induced oxygen free radicals.

Authors:  R Chahine; X Chen; N Yamaguchi; J de Champlain; R Nadeau
Journal:  J Mol Cell Cardiol       Date:  1991-03       Impact factor: 5.000

View more
  18 in total

1.  Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart.

Authors:  Narumi Hashikawa-Hobara; Noel Yan-Ki Chan; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2011-10-19       Impact factor: 4.030

2.  E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role.

Authors:  Silvia Aldi; Alice Marino; Kengo Tomita; Federico Corti; Ranjini Anand; Kim E Olson; Aaron J Marcus; Roberto Levi
Journal:  FASEB J       Date:  2014-10-15       Impact factor: 5.191

3.  Roles of sensory nerves in the regulation of radiation-induced structural and functional changes in the heart.

Authors:  Vijayalakshmi Sridharan; Preeti Tripathi; Sunil Sharma; Eduardo G Moros; Junying Zheng; Martin Hauer-Jensen; Marjan Boerma
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-01-01       Impact factor: 7.038

Review 4.  Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.

Authors:  Alicia C Reid; Jacqueline A Brazin; Christopher Morrey; Randi B Silver; Roberto Levi
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

5.  Remodeling of intrinsic cardiac neurons: effects of β-adrenergic receptor blockade in guinea pig models of chronic heart disease.

Authors:  Jean C Hardwick; E Marie Southerland; Allison E Girasole; Shannon E Ryan; Sara Negrotto; Jeffrey L Ardell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-29       Impact factor: 3.619

Review 6.  Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.

Authors:  Ioanna Andreadou; Hector A Cabrera-Fuentes; Yvan Devaux; Nikolaos G Frangogiannis; Stefan Frantz; Tomasz Guzik; Elisa A Liehn; Clarissa P C Gomes; Rainer Schulz; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

7.  Aldehyde dehydrogenase type 2 activation by adenosine and histamine inhibits ischemic norepinephrine release in cardiac sympathetic neurons: mediation by protein kinase Cε.

Authors:  Pablo A Robador; Nahid Seyedi; Noel Yan-Ki Chan; Kenichiro Koda; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2012-07-03       Impact factor: 4.030

Review 8.  Substance P in heart failure: the good and the bad.

Authors:  Heather M Dehlin; Scott P Levick
Journal:  Int J Cardiol       Date:  2013-11-12       Impact factor: 4.164

9.  Inotropic and lusitropic effects of calcitonin gene-related peptide in the heart.

Authors:  Mustafa Al-Rubaiee; Pandu R Gangula; Richard M Millis; Robin K Walker; Nsini A Umoh; Valerie M Cousins; Miara A Jeffress; Georges E Haddad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

10.  IgE receptor-mediated mast-cell renin release.

Authors:  Silvia Aldi; Pablo A Robador; Kengo Tomita; Annarita Di Lorenzo; Roberto Levi
Journal:  Am J Pathol       Date:  2013-11-18       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.